Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Infections × Fosfomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Tract Infections 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Infections 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 6 Voriconazole 3 Vancomycin 3 Fluconazole 3 Filgrastim 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Therapeutics 2 Ribavirin 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Moxifloxacin 2 Melphalan 2 Levofloxacin 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Daptomycin 2 Cyclophosphamide 2 Caspofungin 2 threonic acid 1 telavancin 1 telaprevir 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1 liposomal amphotericin B 1 lime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡